Hepatocellular Carcinoma

High-risk chronic hepatitis B patients should be screened for hepatocellular carcinoma

Published in Hepatitis Weekly, September 25th, 2006

Recent research from the People's Republic of China has reported on the clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.

"Clinical features of hepatocellular carcinoma patients are changing because of screening," wrote T.K. Cheung and colleagues, Queen Mary Hospital.

The researchers continued that the aim of the study was "to examine the clinical features of hepatocellular carcinoma patients in Hong Kong and validity of different staging systems."

"A total of 223 Chinese patients with hepatocellular carcinoma were studied. Seventy-eight percent of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2006-09-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry